New research suggests that patients who come off popular GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds far faster than those who halt traditional diet and exercise plans.
Findings released in a leading health publication points out that while overweight people frequently drop substantial amounts of their total mass while using the jabs, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"People purchasing such medications should be cognizant of the danger of fast weight regain when the therapy concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment mass in about a year and a half.
Weighing Therapies
The analysis, which reviewed dozens of studies involving over 9,000 of patients, contrasted the results of these new drugs with conventional dieting.
The team point out that people who lose weight through dieting typically have a less rapid weight regain—approximately 100 grams monthly—after stopping.
Understanding the Fast Regain
Doctors propose the way of the jabs explains the amplified regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement results in hunger is unsuppressed, making binge eating a significant risk."
A Chronic Issue?
The NHS recommend the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts contend that, considering the likelihood of relapse, the therapy might need to be life-long.
This perspective is supported by pharmaceutical companies, who say that the results "underscore the chronic nature of excess weight," akin to managing conditions like hypertension.
Patient Testimonies
People who have come off the medication describe a powerful return of cravings.
"It felt as if a switch activating and you're instantly ravenous," described one woman.
The struggle is compounded if users have not adopted lasting dietary or behavioural changes during treatment.
Growing Interest
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among women compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
Ultimately, researchers emphasize that while these medications are powerful tools for weight loss, they are not a permanent cure and long-term success likely depends on integrated lifestyle support.